Screener
Eligibility screening
Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia
7 US sites in NJ, NY
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.